INCY - Incyte Corporation

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,105,719753,751511,495
Cost of Revenue58,18726,9723,004
Gross Profit1,047,532726,779508,491
Operating Expenses
Research Development581,861479,514347,523
Selling General and Administrative320,673196,614165,772
Non Recurring---
Total Operating Expenses---
Operating Income or Loss144,99850,651-4,804
Income from Continuing Operations
Total Other Income/Expenses Net1,1512,5083,085
Earnings Before Interest and Taxes146,14953,159-1,719
Interest Expense38,74545,60346,828
Income Before Tax107,4047,556-48,547
Income Tax Expense3,1821,025-66
Minority Interest---
Net Income From Continuing Ops104,2226,531-48,481
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income104,2226,531-48,481
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares104,2226,531-48,481